Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Transplacental Aspirin Therapy for Early Onset Fetal Growth

NCT04557475 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT04557475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04557475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Transplacental Aspirin Therapy for Early Onset Fetal Growth
Lead sponsor
Johns Hopkins University
Phase
Phase 3
Overall status
Withdrawn
Start date
June 11, 2022
Completion date
June 11, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth restriction, fetal growth retardation, intrauterine growth restriction, intrauterine growth retardation